Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy
- Resource Type
- Discussion
- Source
- In
The Lancet Haematology June 2021 8(6):e386-e387 - Subject
Analysis and Interpretation Comment - Language
- ISSN
- 2352-3026